ICICI Securities is bullish on Zydus Wellness recommended buy rating on the stock with a target price of Rs 1800 in its research report dated November 07, 2023.

Buy Zydus Wellness; target of Rs 1800: ICICI Securities

Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated November 06, 2023.

Buy Zydus Wellness; target of Rs 1800: Sharekhan

​​Zydus Wellness Products, which manufactures and sells energy drink GLUCON-C and GLUCON-D, had alleged that Cipla Health’s Gluco-C and Gluco-D were deceptively similar to its registered trademarks.

HC restrains Cipla from using ‘Gluco-C’ or ‘Gluco-D’ trademarks

In a move that is brings relief to Zydus Wellness, the Delhi High Court has restrained Cipla Health from using brands Gluco-C and Gluco-D

Delhi HC restrains Cipla Health from using marks Gluco-C, Gluco-D

For FY23, the Glucon-D maker’s standalone net profit stood at ₹66 crore, a 400 percent jump from the previous fiscal

Zydus Wellness gains after Norges Bank sells stake

The Supreme Court on Monday sought the response of a firm to a plea filed by consumer goods company Zydus Wellness challenging an order of the Delhi high court which held that it cannot use the brand name “SugarLite” for its products.

SC seeks response of firm Delhi marketing on plea by Zydus against HC order

Zydus Wellness would be expanding overall distribution network to 3 million retail outlets.

Zydus Wellness Q4 Results Review - Market Share Loss In Malted Food Category A Drag On Volumes: ICICI Direct

Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1740 in its research report dated May 17, 2023.

Buy Zydus Wellness; target of Rs 1740: Sharekhan

Buzzing stocks: The SGX Nifty hinted at an open in the green territory for Indian benchmark indices, NSE Nifty 50 and BSE Sensex. Here’s a look at the key stocks to watch in trade today.

Stocks To Watch: ITC, SBI, HDFC Bank, Zydus Wellness, Vedanta, NDTV, NHPC | The Financial Express

Zydus Wellness Ltd on Wednesday posted a standalone net profit of ₹29 crore for the quarter ended March 31, 2023,

Zydus Wellness standalone Q4 net doubles to ₹29 crore

Zydus Wellness Ltd on Wednesday reported a 9 per cent rise in consolidated net profit at Rs 145.33 crore in the fourth quarter ended March 31, 2023.

Zydus Wellness net profit rise 9% YoY to Rs 145 crore in Jan-Mar quarter

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Zydus Wellness Limited is an integrated consumer company, engaged in the development, production, marketing and distribution of health and wellness products.